Mesenchymal stem cells have therapeutic effects in various different models of disease, but how they work is not always clear. Eva Mezey and her colleagues now propose that such cells may prove beneficial in sepsis—and they work by reprogramming innate immune cells (pages 18–20).
- Krisztián Németh
- Asada Leelahavanichkul
- Éva Mezey
